TOP
2000 |  | ||
| Sino Biopharmaceutical Ltd successfully listed on the Growth Enterprise Market (GEM) of The Stock Exchange of Hong Kong Limited (Stock Code: 0827) | |||
2003 |
| ||
| Sino Biopharmaceutical Ltd successfully listed on the Main Board of The Stock Exchange of Hong Kong Limited (Stock Code: 1177) | |||
2005 |
|  | |
| U.S. eye health giant Bausch & Lomb acquired a controlling stake in Shandong Chia Tai Freda Pharmaceutical Group from Sino Biopharmaceutical Ltd. for US$200 million | Sino Biopharmaceutical Ltd. was awarded “200 Best Companies under $1 Billion in Asia Pacific” by Forbes | ||
2006 |  | ||
| The Company was awarded “Chinese Outstanding Enterprise Achievement Prize” by the Capital Magazine in May, 2006 | |||
2015 |  | ||
| Sino Biopharmaceutical Limited debut in “China's Top 500 Companies” by Fortune China ranking 447 | |||
2016 |  |
| |
| Sino Biopharmaceutical Limited was ranked #410, up 37 spots from the year before in “China's Top 500 Companies” by Fortune China | Sino Biopharmaceutical Limited became one of three public companies to make it on Forbes Asia Fabulous 50 (Fab 50) | ||
